Investment
Features
FeesSafety
Academy
More
Pluang+

Xos unveils rapidly deployable Power Hub energy storage at RE+ 2026 for flexible, scalable power solutions.

Market News
20 Oct 2026
GlobeNewsWire
View Source
Bullish
Xos unveils rapidly deployable Power Hub energy storage at RE+ 2026 for flexible, scalable power solutions.

Xos, Inc. announced its participation in RE+ 2026, showcasing its Power Hub line of rapidly deployable energy storage systems ranging from 210 kWh to 3.1 MWh per unit. These units provide flexible, scalable power solutions that can be quickly connected to grids, generators, or solar arrays, addressing delays in grid connections and supporting diverse applications like data centers, industrial sites, and remote operations. The Power Hub is designed and manufactured in the U.S., offering fast deployment without permanent installation, and can be combined for multi-megawatt utility-scale projects. This innovation aims to help customers meet growing power demands without waiting years for traditional grid upgrades.

Xos and its rapidly deployable Power Hub energy storage system provide context for the energy sector's market activity. For readers following energy stocks, here is Pluang's market snapshot as of Oct 21, 2026 03:42 WIB: Among 79 priced US energy stocks, 44 rose and 33 fell. Notable movers include Solaris Energy Infrastructure Inc. (SEI) at USD 63.07 with a 1-day change of -4.09% and a typical hold time of 3 days, Kinder Morgan Inc. (KMI) at USD 34.16 with a 1-day change of +4.08% and Pluang order activity showing 28% sell and 72% buy over a typical hold time of 151 days, and Delek US Holdings Inc. (DK) at USD 77.58 with a 1-day change of +3.33% and a typical hold time of 6 days.

More News

Moody's Q3 2026 earnings preview highlights credit ratings and AI-driven analytics growth.

Moody's Q3 2026 earnings preview highlights credit ratings and AI-driven analytics growth.

Moody's is expected to report Q3 2026 earnings of around $4.25 per share on revenue near $2.08 billion, driven by steady demand for credit ratings and growth in Moody's Analytics, especially from recurring subscriptions and AI tools. While Moody's In...

Company Fundamentals
Neutral
49 minutes ago
Raymond James raises Rapport Therapeutics price target to $86 after positive Phase 2 trial for bipolar mania drug.

Raymond James raises Rapport Therapeutics price target to $86 after positive Phase 2 trial for bipolar mania drug.

Raymond James increased its price target for Rapport Therapeutics to $86 following positive Phase 2 trial results of RAP-219, a drug treating acute bipolar mania. The trial showed statistically significant improvement in patients and a favorable safe...

Analyst Insights
Bullish
1 hour ago
Heartland Express Q3 revenue falls 8.7%, misses estimates but returns to profit

Heartland Express Q3 revenue falls 8.7%, misses estimates but returns to profit

Heartland Express reported a third-quarter 2026 revenue decline of 8.7% to $179.5 million, missing analyst estimates. Despite lower revenue, the company returned to profitability with a net income of $1.0 million, compared to a loss last year. The op...

Company Fundamentals
Bearish
1 hour ago
CMMB opens new Distribution Center at Brethren Service Center to boost global medicine access.

CMMB opens new Distribution Center at Brethren Service Center to boost global medicine access.

Catholic Medical Mission Board (CMMB) held a ribbon-cutting ceremony for its new Distribution Center at the Brethren Service Center in New Windsor, Maryland. This move enhances CMMB's Access to Medicines Program by expanding operational capacity and ...

Others
Neutral
1 hour ago
Myriad Genetics upgraded to Neutral as it sells prenatal unit to Labcorp for $210M.

Myriad Genetics upgraded to Neutral as it sells prenatal unit to Labcorp for $210M.

Piper Sandler upgraded Myriad Genetics from Underweight to Neutral and set a $5.00 price target after the company agreed to sell its prenatal health testing business to Labcorp for $210 million in cash. This sale includes several prenatal tests and i...

Analyst Insights
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App